Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Unlike full-length growth hormone, AOD-9604 selectively targets fat metabolism through beta-3 adrenergic receptor pathways without affecting insulin sensitivity or IGF-1 levels
Acetyl Tetrapeptide-5 for Under-Eye Bags This innovative peptide is specifically designed to combat the appearance of under-eye bags by addressing multiple underlying causes: Reducing fluid accumulation, which is a major contributor to the formation of under-eye bags, by improving the skins natural drainage ability
ARA-290 received FDA Orphan Drug Designation for this indication TRPV1-mediated pain models ARA-290 demonstrated specific inhibition of TRPV1 channel activity, relieving capsaicin-induced mechanical hypersensitivity in pre-clinical nociceptor models Complex Regional Pain Syndrome (CRPS) investigational studies have examined ARA-290 in CRPS models due to its dual anti-inflammatory and nociceptor-targeting mechanism Chronic neuropathic pain multiple studies confirm ARA-290 reduces neuroinflammation in the spinal cord by suppressing TNF-, IL-1, and other pro-inflammatory cytokines that maintain chronic pain states Neuroprotection and CNS Research: Cerebral ischaemia/stroke models Wang et al
Hansen HH, Jensen MM, Overgaard A, Weikop P, Mikkelsen JD
The convergence of these mechanisms supports research into the multi-layered coordination of signaling in inflammatory and reparative biological systems
